Galapagos NV at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm James Quigley, European pharma & biotech analyst at JPMorgan, and it's my pleasure to welcome you all to the Galapagos presentation. With us today is the COO and CFO, Bart Filius. After Bart's presentation, there will be a breakout in the Yorkshire room, which is just on -- as you come out of the doors, to our left.
So with that, over to you, Bart.
Thank you very much, James, and thanks for having me here at the conference, and a warm welcome this morning to everyone here in the U.S. and also to those that are listening in to the live stream through Internet and especially also our friends, investors and colleagues from Europe that are participating.
So I'm really happy to be here and to get a chance for about half an hour to present the highlights on Galapagos. After a special year 2019, I can say, we're up to a very interesting and very exciting year 2020 as well.
So let me take
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
